From: A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects
Characteristic | Placeboa | Interferon beta 1aa | Pvalue |
---|---|---|---|
Age at informed consent (yrs) | 64.57 ± 6.4 | 63.0 ± 9.07 | 0.57 |
Height (cm) | 165.11 ± 7.52 | 163.0 ± 9.01 | 0.42 |
Weight (kg) | 71.59 ± 9.92 | 68.17 ± 10.04 | 0.27 |
Systolic pressure (mmHg) | 131.05 ± 7.56 | 164.74 ± 18.26 | 0.31 |
Diastolic pressure (mmHg) | 79.47 ± 6.64 | 116.26 ± 19.2. | 0.26 |
Pulse rate (bpm) | 70.94 ± 11.88 | 71.56 ± 6.97 | 0.86 |
Sexb | 8 (male); 11 (female) | 8 (male); 15 (female) | 0.62 |
Concomitant age-related diseases different from AD | 14 (yes); 4 (no) | 14 (yes); 8 (no) | 0.94 |